[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354068-105":59,"doc-detail-354068-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pink1-mediated-mitophagy-enhances-breast-cancer-proliferation-through-metabolic-reprogramming","PINK1-mediated mitophagy enhances breast cancer proliferation through metabolic reprogramming","","Breast cancer remains a leading cause of cancer-related mortality among women, with aggressive subtypes such as triple-negative breast cancer (TNBC) lacking effective targeted therapies. PTEN-induced kinase 1 (PINK1) regulates mitochondrial homeostasis through mitophagy, yet its role in breast cancer progression and metabolic control is insufficiently characterized. This study evaluates PINK1 oncogenic effects and downstream metabolic reprogramming through gain- and loss-of-function experiments, mitophagy and metabolic assays, and functional analyses, identifying the PINK1–PGK2 axis as a critical mechanism and potential therapeutic target.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pink1-mediated-mitophagy-enhances-breast-cancer-proliferation-through-metabolic-reprogramming/354068/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pink1-mediated-mitophagy-enhances-breast-cancer-proliferation-through-metabolic-reprogramming/354068.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",18,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of the study regarding PINK1 in breast cancer?","Question",{"text":113,"@type":114},"The study investigates how PINK1 promotes breast cancer proliferation by influencing metabolic reprogramming, with an emphasis on mitophagy-related regulation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is mitophagy evaluated in this research?",{"text":118,"@type":114},"Mitophagy is assessed using LC3-II levels, Parkin expression, and transmission electron microscopy.",{"name":120,"@type":111,"acceptedAnswer":121},"What downstream target links PINK1 to metabolic changes in breast cancer?",{"text":122,"@type":114},"Phosphoglycerate kinase 2 (PGK2) is identified as a downstream target of PINK1, and knocking down PGK2 reverses PINK1-mediated proliferation, migration, and invasion.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354068,1790211673,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","ONCOLOGY REPORTS 55: 112, 2026  \nPINK1‑mediated mitophagy enhances breast cancer proliferation through metabolic reprogramming  \nZONG JIN GUO 1* , QIAN YU2* , RUI SHA3 , WEI LI4 and HUI JUAN DAI5  \n1  \nDivision of Interventional Radiology, The University of Hong Kong‑Shenzhen Hospital, Shenzhen, Guangdong 518053, P.R. China; 2  \nDepartment of Breast Surgery, Huai'an Maternal and Child Healthcare Center, Huai'an, Jiangsu 223002, P.R. China; 3Department of Thyroid and Breast Surgery, The First Affiliated Hospital ofWannan Medical College (Yijishan Hospital of  \n4  \nWannan Medical College), Wuhu, Anhui 241001, P.R. China; Department of Oncology Radiotherapy, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China; 5Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China  \nReceived September 23, 2025; Accepted January 27, 2026  \nDOI: 10. 3892/or.2026.9117  \nAbstract . Breast cancer is a predominant cause of cancer‑related mortality among women, particularly aggres‑ sive subtypes such as triple‑negative breast cancer (TNBC), which currently lack effective targeted therapies . While PTEN‑induced kinase 1 (PINK1) is known for its role in maintaining mitochondrial homeostasis via mitophagy, its specific contributions to breast cancer progression and meta‑ bolic regulation remain poorly defined. The present study aimed to investigate the oncogenic potential of PINK1 and its influence on metabolic reprogramming. To achieve this, the PINK1 expression levels in breast cancer tissues and cell lines were assessed. Gain‑ and loss‑of‑function methodologies were employed in luminal (MCF‑7) and TNBC (MDA‑MB‑231) cells. Then, mitophagy was evaluated by measuring LC3‑II levels, Parkin expression and utilizing transmission electron microscopy. Glucose uptake assays and metabolite quantifi‑ cation (including pyruvate and acetyl‑CoA) were conducted. Reverse transcription‑quantitative polymerase chain reaction identified phosphoglycerate kinase 2 (PGK2) as a downstream target of PINK1 . Functional assays were then performed to  \nCorrespondence to: Dr Wei Li, Department of Oncology Radiotherapy, The Affiliated Huai'an Hospital of Xuzhou Medical University, 99 Huaihai West Road, Huai'an, Jiangsu 223002, P.R. China  \nE‑mail: [240036546@qq.com](240036546@qq.com)  \nDr Hui Juan Dai, Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, 1630 Dongfang Road, Shanghai 200127, P.R. China  \nE‑mail: [daihuijuan@renji.com](daihuijuan@renji.com)  \n*Contributed equally  \nKey words: PTEN‑induced kinase 1‑phosphoglycerate kinase 2 axis, mitophagy, glycolysis, breast cancer, therapeutic target  \nexamine the proliferation, migration and invasion of cells with PINK1 overexpression. The results demonstrated that PINK1 overexpression increased mitophagy and induced a glycolytic phenotype, characterized by enhanced glucose uptake and elevated PGK2 levels. Elevated concentrations of pyruvate and acetyl‑CoA indicated increased metabolic flux. Functionally, PINK1 promoted proliferation, migration and invasion in both cell types. Knockdown of PGK2 reversed these effects, underscoring its critical role in PINK1‑mediated metabolic reprogramming. Transcriptomic data obtained from online databases revealed a correlation between high PINK1 expres‑ sion and immunosuppressive tumor microenvironments, as well as poor prognosis. The PINK1‑PGK2 axis constitutes a critical mechanism linking mitophagy to glycolytic repro‑ gramming in breast cancer, representing a novel therapeutic target, particularly for TNBC. Targeting this axis may yield new strategies for addressing treatment‑resistant, metabolically adaptive breast cancer.  \nIntroduction  \nBreast cancer is the most prevalent cancer among women globally. GLOBOCAN estimated there would be 2.3 million new cases of breast cancer in 2022; breast cancer also caused 670,000 deaths in 2022, ac","cbCaikI4ZlnCKaMh","https://ap.wps.com/l/cbCaikI4ZlnCKaMh","pdf",11632162,24,"English","# Introduction\n# Materials and methods\n## Mitophagy assessment\n## Metabolic assays\n## Gene expression and target identification\n# Results\n## PINK1 promotes mitophagy and glycolytic phenotype\n## PGK2 is required for PINK1-driven effects\n## Clinical and transcriptomic correlations","[{\"question\":\"What is the main focus of the study regarding PINK1 in breast cancer?\",\"answer\":\"The study investigates how PINK1 promotes breast cancer proliferation by influencing metabolic reprogramming, with an emphasis on mitophagy-related regulation.\"},{\"question\":\"How is mitophagy evaluated in this research?\",\"answer\":\"Mitophagy is assessed using LC3-II levels, Parkin expression, and transmission electron microscopy.\"},{\"question\":\"What downstream target links PINK1 to metabolic changes in breast cancer?\",\"answer\":\"Phosphoglycerate kinase 2 (PGK2) is identified as a downstream target of PINK1, and knocking down PGK2 reverses PINK1-mediated proliferation, migration, and invasion.\"}]","PINK1-mediated mitophagy enhances breast cancer proliferation through metabolic reprogramming | PDF",1790108693,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efa0ba9ad751e02124551acf5d1a5473.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f01537ba55fcc5aed6693314e25b40ef.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06973bf84c3bfe32fd0390e08f9747c8.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5436c5c75baaebfc463ccc22a698cbee.webp",980,1353]